title: Reconstituted killer cell inhibitory receptors for major histocompatibility complex class I molecules control mast cell activation induced via immunoreceptor tyrosine-based activation motifs.
abstract: Natural killer and T cells express at their surface, members of a multigenic family of killer cell inhibitory receptors (KIR) for major histocompatibility complex Class I molecules. KIR engagement leads to the inhibition of natural killer and T cell activation programs. We investigated here the functional reconstitution of KIR in a non-lymphoid cell type. Using stable transfection in the RBL-2H3 mast cell line, we demonstrated that (i) KIR can inhibit signals induced by FcepsilonRIgamma or CD3zeta polypeptides that bear immunoreceptor tyrosine-based activation motifs; (ii) two distinct immunoreceptor tyrosine-based inhibition motifs-bearing receptors, i.e. KIR and FcgammaRIIB, use distinct inhibitory pathways since KIR engagement inhibits the intracellular Ca2+ release from endoplasmic reticulum stores, in contrast to FcgammaRIIB, which only inhibits extracellular Ca2+ entry; (iii) KIR require co-ligation with an immunoreceptor tyrosine-based activation motif-dependent receptor to mediate their inhibitory function. This latter finding is central to the mechanism by which KIR selectively inhibit only the activatory receptors in close vicinity. Taken together our observations also contribute to define and extend the family of immunoreceptor tyrosine-based inhibition motif-bearing receptors involved in the negative control of cell activation.
authors.affiliation: Centre d'Immunologie INSERM/CNRS de Marseille-Luminy, Case 906, 13288 Marseille Cedex 09, France.
authors.forename: M
authors.initials: M
authors.lastname: Bléry
authors.forename: J
authors.initials: J
authors.lastname: Delon
authors.forename: A
authors.initials: A
authors.lastname: Trautmann
authors.forename: A
authors.initials: A
authors.lastname: Cambiaggi
authors.forename: L
authors.initials: L
authors.lastname: Olcese
authors.forename: R
authors.initials: R
authors.lastname: Biassoni
authors.forename: L
authors.initials: L
authors.lastname: Moretta
authors.forename: P
authors.initials: P
authors.lastname: Chavrier
authors.forename: A
authors.initials: A
authors.lastname: Moretta
authors.forename: M
authors.initials: M
authors.lastname: Daëron
authors.forename: E
authors.initials: E
authors.lastname: Vivier
mesh_terms: D000818:Animals; D017252:CD3 Complex / Q000378:metabolism; D002118:Calcium / Q000378:metabolism; D004721:Endoplasmic Reticulum / Q000378:metabolism; D018397:Equidae; D015236:HLA-C Antigens / Q000378:metabolism; D015395:Histocompatibility Antigens Class I / Q000378:metabolism*; D006801:Humans; D007694:Killer Cells, Natural / Q000502:physiology*; D008407:Mast Cells / Q000502:physiology*; D051379:Mice; D008954:Models, Biological; D011487:Protein Conformation; D051381:Rats; D017455:Receptors, IgE / Q000378:metabolism*; D011971:Receptors, Immunologic / Q000378:metabolism*; D012701:Serotonin / Q000378:metabolism; D014443:Tyrosine / Q000378:metabolism*
chemical_list: D017252:CD3 Complex; D015236:HLA-C Antigens; C038653:HLA-C*03 antigen; D015395:Histocompatibility Antigens Class I; D017455:Receptors, IgE; D011971:Receptors, Immunologic; D012701:Serotonin; D014443:Tyrosine; D002118:Calcium